287
Participants
Start Date
September 8, 2020
Primary Completion Date
June 21, 2022
Study Completion Date
June 21, 2022
RO6889450
Participants will receive oral RO6889450 QD.
Placebo
Participants will receive oral placebo QD.
Risperidone
Participants will receive oral risperidone QD.
Communal Non-Commercial Enterprise Cherkasy Regional Psychiatric Hospital of Cherkasy RC, Smila
CBH Health LLC, Gaithersburg
Communal NPE Vinnytsia Reg. Clin. Psychoneurolog. Hosp. n.a. O.I. Yushchenko of Vinnytsia RC, Vinnytsia
Atlanta Center For Medical Research, Atlanta
Galiz Research, LLC, Hialeah
Premier Clinical Research Institute - Miami - BTC - PPDS, Miami
Innovative Clinical Research, Inc., Lauderhill
Research Centers of America - ERG, Oakland Park
Poltava Regional Psychiatry Hospital, Poltava
Neuro-Behavioral Clinical Research, Inc., Canton
Midwest Clinical Research Center - ERG - PPDS, Dayton
Uptown Research Institute, Chicago
Communal Non-Commercial Enterprise of Kharkiv RC Regional clinical psychiatric hospital #3, Kharkiv
Woodland International Research Group Inc., Little Rock
Public NPE Kherson Regional Institution of Mental Care of Kherson RC, Kherson
Pillar Clinical Research LLC, Garland
Community Clinical Research Inc., Austin
ProScience Research Group, Culver City
CNRI - Los Angeles, LLC, Pico Rivera
CITrials, Inc., Bellflower
California Clinical Trials Medical Group managed by Parexel, Glendale
ASCLEPES Research Centers, Panorama City
Schuster Medical Research Institute, Sherman Oaks
Synergy San Diego, Lemon Grove
California Neuropsychopharmacology Clinical Research Institute, LLC, San Diego
Artemis Institute For Clinical Research LLC - San Diego - ClinEdge - PPDS, San Diego
CITrials, Inc., Riverside
Collaborative Neuroscience Network, Inc., Garden Grove
NRC Research Institute, Orange
Psychiatry Hospital #1 n.a. P.P.Kashchenko, Saint Petersburg
Leningradskiy Regional Psychoneurologic Dispensary, Saint Petersburg
Psychiatric Hospital St Nicholas the Wonderworker, Saint Petersburg
FSBI National Medical Research Centre of Psychiatry and Neurology n.a. V.M. Bekhterev of MoH of RF, Sankt-peterburg
City Psychiatry Hospital #3 n.a. I.I. Skvortsov-Stepanov, Saint Petersburg
Stavropol Regional Psychiatry Hospital #2, Stavropol
Saratov regional clinical psychoneurological hospital St Sofii, Saratov
Tomsk National Scientific Medical Center of Russian Academy of Sciences, Tomsk
National Center of Neurology and Psychiatry, Tokyo
Seishinkai Okehazama Hospital Fujita Kokoro Care Center, Toyoake
Kyiv Medical Regional Union Psychiatry, Kylv
Hoffmann-La Roche
INDUSTRY